Q Precious & Battery Metals Corp. (QMET) Extends Nova Scotia Natural Hydrogen Discovery with Results up to 1,840 ppm
Expanded Sampling to the North and East Confirms Multiple High-Grade Hydrogen Zones August 21, 2025 2:00 AM EDT | Source: Q Precious & Battery Metals Halifax, Nova Scotia–(Newsfile Corp. – August 21, 2025) – Q Precious & Battery Metals Corp. (CSE: QMET) (OTC Pink: BTKRF) (FSE: 0NB) (“QMET” or the “Company”) is pleased to […]
NOVAGOLD and Paulson’s Alaska Site Visit Builds Momentum in
Meetings with Alaska Native Corporations, government officials and key stakeholders underscore positive momentum for the new Donlin Gold partnership and its updated project development plan. Donlin Gold contract awarded to prepare the Request for Proposals (RFP) to commence the updated Bankable Feasibility Study (BFS) and expects to select top-tier qualified engineering firm(s) by the fourth […]
Glenstar Minerals Inc. Announces Upsized $3 Million Private Placement Financing
August 20, 2025 7:12 PM EDT | Source: Glenstar Minerals Inc. Vancouver, British Columbia–(Newsfile Corp. – August 20, 2025) – Glenstar Minerals Inc. (CSE: GSTR) (“Glenstar” or the “Company”) is pleased to announce that as a result of strong investor demand, the Company and Hampton Securities Limited (the “Agent”) have amended their agreement to increase the […]
Rubicon Technology, Inc. to acquire Janel Group LLC
BENSENVILLE, Ill. and NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) — Rubicon Technology, Inc. (OTCQB:RBCN) (“Rubicon”) and Janel Corporation (OTCQX:JANL) (“Janel Corp”) today announced that they have entered into a definitive merger agreement, pursuant to which Rubicon will acquire Janel Group LLC (“Janel Group”) with Janel Group becoming a wholly owned subsidiary of Rubicon and […]
Zacks Small Cap Research – CPKF Second Quarter Diluted EPS Beats our Estimate by $0.04
By Ann Heffron, CFA, CPA OTC:CPKF READ THE FULL CPKF RESEARCH REPORT CPKF’s (OTC:CPKF) second quarter net earnings increased $0.1 million, or 4%, to $3.1 million year over year, while 2025’s second quarter diluted EPS rose $0.02, or 7%, to $0.67. This was better than our estimate, which had called for a slight decline in […]
Brazil Potash Executa Acordo Definitivo De Offtake Com
Acordo apoia o Plano Nacional de Fertilizantes do Brasil ao produzir um mineral crítico que se baseia nas forças da cadeia de suprimentos agrícolas domésticos para os agricultores Acordo Vinculativo de Take-or-Pay representa o segundo marco comercial importante de offtake seguindo os contratos da AMAGGI que agora totalizam ~1,5 milhão de toneladas anuais, representando ~60% […]
Brazil Potash Executes Definitive Offtake Agreement With
Agreement supports Brazil’s National Fertilizer Plan by producing a critical mineral that builds on the strengths of the domestic agricultural supply chain for farmers Binding Take-or-Pay Agreement represents second major offtake commercial milestone following AMAGGI contracts now totaling ~1.5 million tons annually, representing ~60% of planned production capacity MANAUS, Brazil, Aug. 20, 2025 (GLOBE NEWSWIRE) […]
Zacks Small Cap Research – CTSO: CytoSorbents Announces the De Novo denial on DrugSorb-ATR was upheld by the FDA. However, a Path to Approval Was Also Provided by the Agency.
By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT Regulatory Update on DrugSorb-ATR On August 20, 2025, the company announce that it had received an FDA appeal decision following its July 2025 in-person supervisory administrative review (appeal) meeting with FDA under 21 CFR 10.75. The appeal was in response to an April 25, 2025 FDA denial letter of […]
West High Yield (W.H.Y.) Resources Ltd. Welcomes Final EAO Decision on Record Ridge Magnesium Project
August 20, 2025 1:44 PM EDT | Source: West High Yield (W.H.Y.) Resources Ltd. Calgary, Alberta–(Newsfile Corp. – August 20, 2025) – West High Yield (W.H.Y.) Resources Ltd. (TSXV: WHY) (FSE: W0H) (the “Company” or “West High Yield“) is very pleased to announce that the British Columbia Environmental Assessment Office (the “EAO “) has issued […]
Zacks Small Cap Research – DWTX: Over 50 Patients Enrolled Thus Far in Phase 2b Halneuron® Trial; Interim Read Out in 4Q25
By David Bautz, PhD NASDAQ:DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Over 50 Patients Enrolled Thus Far in Phase 2b Trial of Halneuron® in CINP Dogwood Therapeutics, Inc. (NASDAQ:DWTX) is currently conducting the Phase 2b HALT-CINP (Halneuron® Treatment of Chemotherapy-Induced Neuropathic Pain) trial. This is a four-week study that will examine the safety […]